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        The clinical course and prognosis of multiple 
sclerosis (MS) and other encephalitic diseases is 
highly variable between patients. In MS, both 
symptoms and prognosis are correlated with the 
infl  ammation of specifi  c regions of the central 
nervous system (CNS). Clinical studies have 
found that disease aff  ecting the cerebellum has a 
particularly poor prognosis and rapid progres-
sion (  1  –  5  ). Previous work in the well studied 
mouse MS model experimental autoimmune 
encephalomyelitis (EAE) demonstrated that an-
tigen and genetic background infl  uence the dis-
tribution of lesions and clinical signs (  6  –  8  ). 
  Recent work demonstrated that neuroin-
fl  ammation is associated with a   “  conversation  ”   
or exchange of signals between the infl  amma-
tory cells and cells in the CNS (  9  ).   “  Classical  ”   
or   “  typical  ”   EAE is dominated by clinical signs 
associated with inflammatory lesions in the 
white matter of the spinal cord (  10  ). Further, in 
classical EAE, myelin-specifi  c Th1 cells can ef-
fectively penetrate the parenchyma of the spi-
nal cord but not the cerebrum, brain stem, or 
cerebellum (  11  ). Instead, in the cerebellum, 
there is perivascular monocyte and T cell accu-
mulation with little attendant pathogenesis as 
indicated by either histological analysis or clin-
ical symptoms (  8  ). 
  However, experiments with a TCR trans-
genic animal found that the clinical symptoms 
of spontaneous disease changed from classical 
to atypical when the transgenic TCR was bred 
to the IFN-       –  null background (  12  ). The site of 
pathology was shifted from the spinal cord to 
the cerebellum and brain stem, resulting in dis-
turbances in balance and coordination, suggest-
ing that characteristics of the initiating T cells 
other than antigen specifi  city play an important 
role in directing the site of pathogenesis (  7  ). 
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  The localization of infl  ammatory foci within the cerebellum is correlated to severe clinical 
outcomes in multiple sclerosis (MS). Previous studies of experimental autoimmune enceph-
alomyelitis (EAE), a model of MS, revealed distinct clinical outcomes correlated with the 
capacity of the animal to produce IFN-    . Outcomes were linked to localization of infl  am-
matory cells in either the spinal cord (wild type [WT]) or the cerebellum and brain stem 
(IFN-     defi  cient). We demonstrate, using an adoptive transfer system, that the ability of 
the central nervous system (CNS) to sense pathogenic T cell  –  produced IFN-     during EAE 
initiation determines the sites of CNS pathogenesis. Transfer of WT Th1 cells into IFN-     
receptor  –  defi  cient mice results in pathogenic invasion of the brain stem and cerebellum 
with attendant clinical symptoms, which are identical to the disease observed after transfer 
of IFN-      –  defi  cient T cells to WT hosts. Infl  ammation of the spinal cord associated with 
classical EAE is abrogated in both IFN-      –  defi  cient systems. Cotransfer of CNS antigen-
specifi  c WT Th1 cells with IFN-      –  defi  cient T cells is suffi  cient to restore spinal cord inva-
sion and block cerebellar and brain stem invasion. These data demonstrate that interaction 
between IFN-     and host CNS cells during the initiation of EAE can selectively promote or 
suppress neuroinfl  ammation and pathogenesis. 
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the adoptive transfer system both to allow dissection of the 
components involved in IFN-      signaling during EAE and to 
avoid use of the exogenous infl  ammatory mediators (my-
cobacteria and pertussis toxin) used to induce active EAE. 
  As previously reported, we found that transfer of IFN-       –
  defi  cient Th1-polarized CNS antigen-specifi  c activated CD4  +   
T cells resulted in an atypical clinical course of EAE (  7, 12  ). 
The most common clinical symptoms noted were vertigo/
dysequilibrium, as measured by a mouse  ’  s tendency to lean, 
turn, and/or roll to one side, and ataxia (  Table I  ).   Some mice 
also demonstrated symptoms of limb dysfunction associated 
with dystonia of the tail and limbs rather than the fl  accid pa-
ralysis associated with classical EAE (  Table I  ). Mice that 
received WT Th1 (IL12 treated) displayed classical EAE 
symptoms of ascending paralysis (  Table I  ). The ascending pa-
ralysis was associated with monocytic infl  ammation of white 
matter tracts in the spinal cord, with negligible parenchymal 
infi  ltration of the cerebellum (  Fig. 1 A  ).   
  The induction of atypical EAE symptoms was associated 
with severe, often laterally asymmetrical, infl  ammation of the 
cerebellum and brain stem with facial and vestibulocochlear 
nerve involvement (  Fig. 1, A and B  ). The infl  ammatory in-
fi  ltrate consisted of mostly mononuclear cells, containing 
lymphocytes, monocytes, and macrophages, with a small 
number of accompanying granulocytic cells (  Fig. 1 C   and 
Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20080155/DC1). In contrast, very little infl  ammation was 
found in the spinal cords of mice that received IFN-       –  defi  -
cient myelin/oligodendrocyte glycoprotein (MOG)  –  specifi  c 
T cells (  Fig. 1 A  ). 
  Previous work had suggested that the adjustment in re-
gional specifi  city of encephalitogenic T cells may directly re-
late to changes in T cell lineage associated with the absence 
of IFN-      during the initial activation of naive myelin-spe-
cifi  c T cells (  7  ). Recent studies have outlined the complicated 
relationship between IFN-      and IL-17 lineage commitment 
(  13  –  16  ). Specifi  cally, previous studies demonstrated a marked 
  Several previous models in which pathogenesis was redi-
rected to the cerebellum and brainstem involved cells from an 
IFN-       –  null background (  7, 12  ). These studies postulated that 
the absence of IFN-       ’  s negative eff  ect on lymphocyte prolifer-
ation or IFN-       ’  s eff  ects on antigen presentation or sensitivity 
to apoptosis may explain the importance of the IFN-      in di-
recting regional pathogenesis. In this paper, we have explored 
two competing explanations: fi  rst, IFN-      production may di-
rectly infl  uence the capacity of particular areas of the CNS to 
support infl  ammation and pathogenesis; or second, the eff  ects 
of IFN-      on the lineage commitment of cells produced by im-
munization with CFA may determine the capacity of cells to 
form lesions at specifi  c anatomical locations. The latter hypoth-
esis overlaps with the antigen presentation hypothesis but also 
includes the possibility that the newly described Th17 lineage 
may be involved, as IFN-      has been demonstrated to be a neg-
ative factor in Th17 development (  13  –  16  ). The possibility that 
increased levels of IL-17 production were involved was sup-
ported by a recent study that suggested a signifi  cant role for 
Th17 cells in determination of lesion localization (  17  ). 
  To address these possibilities, we have produced myelin-
specifi  c CD4  +   T cell lines from WT and IFN-       –  defi  cient mice 
and expanded these lines in vitro under either Th1 or Th17 
polarizing conditions, before transferring these cells to examine 
the pathological and clinical characteristics of neurological dis-
ease induced in either WT or IFN-      receptor (IFN-     R)  –  defi  -
cient mice. Our results indicate that it is the absence of IFN-      
rather than increased numbers of IL-17  –  producing cells that 
accounts for pathogenesis in the cerebellum and brainstem. 
    RESULTS   
  Increased numbers of IL-17  –  producing cells are not 
suffi  cient to drive atypical EAE 
  We generated cell lines specifi  c for the MOG  35-55   peptide in 
the context of I-A  b   in both WT and IFN-       –  defi  cient mice to 
examine the mechanisms involved in the induction of atypi-
cal EAE previously observed in IFN-       –  defi  cient mice. We used 
  Table I.       Pathogenic IFN-     –  defi  cient T cells induce atypical EAE  
Injected cells WT-IL12  –  treated 
cells
WT-IL23  –  treated 
cells
IFN-     KO-IL12  –
  treated cells
IFN-     KO-IL23  –  treated 
cells
Incidence of disease 5/5 5/5 14/15 15/15
Incidence of limb dysfunction 5/5 5/5 5/15 2/15
Incidence of fl  accid paralysis 5/5 5/5 0/15 0/15
Incidence of dystonia 0/5 0/5 5/15 2/15
Mean day of onset of clinical signs of limb dysfunction 7.6   ±   0.6 20.8   ±   1.5 13.4   ±   4.2 9.0   ±   0
Mean peak limb dysfunction clinical score 2.5   ±   0 3.8   ±   0.5 1.5   ±   0.7 1.0   ±   0
Incidence of non-classical EAE 0/5 0/5 14/15 15/15
Mean day of onset of clinical signs of non-classical EAE N  A NA 14.4    ±   4.2 13.1   ±   3.4
Vertigo 0/5 0/5 11/14 12/15
Ataxia 0/5 0/5 9/14 9/15
MOG  35-55 -specifi  c T cell lines were generated in either C57BL/6 (WT) or IFN-     – defi  cient (IFN-      KO) mice. T cell lines were produced in the presence either of IL-12 or IL-
23  + TGF-    + IL-6 + anti – IFN-     as described in Materials and methods. The T cell lines were then injected i.v. Mice were examined over time for clinical signs of limb dysfunction, 
vertigo/disequilibrium, and ataxia. Results are representative of two separate experiments. Results are shown   ±   SD.JEM VOL. 205, October 27, 2008 
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  Cotransferred Th1 cells prevent cerebellar disease in a dose-
dependent manner 
  As the clinical outcomes of classical and atypical disease ap-
peared to be mutually exclusive, we wished to examine the 
relative dominance of the traffi   cking patterns associated with 
both WT Th1 cells and IFN-       –  defi  cient cells. To do so, we 
mixed MOG  35-55  -specifi  c encephalitogenic cell lines from 
IFN-       –  defi  cient and WT mice at varying ratios and exam-
ined the mixed cell populations for their capacity to induce 
atypical and/or classical EAE clinical symptoms. Cotransfer 
of WT and IFN-       –  defi  cient MOG-specifi  c Th1-polarized 
cells at a 1:1 ratio resulted in induction of classical EAE in the 
majority of mice treated (  Table II  ).   Histological examination 
revealed no diff  erence in cell localization between mice with 
classical EAE that received either 1:1 mixed transfer popula-
tions or WT Th1 cells alone (  Fig. 3  ).   Cotransfer of WT non-
CNS antigen-specifi  c (anti-OVA) Th1-polarized cells and 
IFN-       –  defi  cient MOG-specifi  c Th1-polarized cells at a 1:1 
ratio resulted in atypical disease, demonstrating that antigen-
specifi  c signaling of transferred Th1 cells was required to de-
termine the site of lesion localization (  Table II  ). Thus, IFN-      
production in a large fraction of CNS antigen-specifi  c trans-
ferred cells is suffi   cient to localize infl  ammatory infi  ltration to 
the spinal cord and prevent infl  ammation of the cerebellum. 
  We further explored the threshold of cotransferred Th1 
pathogenic cells necessary to determine lesion localization by 
administering populations of WT Th1 and IFN-       –  defi  cient 
MOG-specifi  c T cells mixed at lower ratios. Reduction of the 
ratio of Th1/IFN-       –  defi  cient cells to 1:10 largely ablated the 
capacity of Th1 cells to prevent infl  ammation of the cerebel-
lum (  Table II  ). Interestingly, injection of Th1/IFN-       –  defi  cient 
cells at a 1:5 ratio gave mixed clinical results, with some mice 
demonstrating classical EAE symptoms, some mice displaying 
atypical symptoms, and a fraction of mice that exhibited both 
sets of clinical symptoms (  Table II  ). Immunohistochemical 
increase in IL-17  –  producing cells diff  erentiated under IFN-
       –  defi  cient conditions. We hypothesized that an increase in 
IL-17  –  producing cells associated with IFN-      defi  ciency was 
responsible for the change in cell localization during EAE. 
To address this hypothesis we produced MOG  35-55   peptide-
specifi  c T cell lines from both WT and IFN-       –  defi  cient mice 
and cultured the lines under conditions previously reported 
to polarize cells to either Th1 or Th17 phenotypes. 
  It is clear that immunization with CFA produces a popu-
lation of cells skewed toward the Th1 phenotype (  Fig. 2  , WT 
cells expanded in IL-2 alone).   However, Th17 conditions 
(IL-23, IL-6, and TGF-     ) increase the fraction of cells ex-
pressing IL-17, especially IFN-      IL-17 double producers. As 
expected, MOG-specifi  c T cell lines produced from IFN-       –
  defi  cient mice contained greater numbers of IL-17  –  produc-
ing cells than Th1 lines produced from WT mice (  Fig. 2  ). 
However, IFN-       –  defi  cient lines cultured under Th1 polar-
izing conditions contained numbers of IL-17  –  producing T 
cells far lower than the numbers of IL-17  –  producing cells 
present in WT cell lines developed under Th17 polarizing 
conditions (  Fig. 2  ). An increase in IL-17  –  producing cells to 
levels greater than that associated with IFN-      defi  ciency was 
not suffi   cient to induce changes in encephalitogenic cell 
localization equivalent to those associated with IFN-      defi  -
ciency (  Table I  ). Instead, WT T cells polarized to produce 
IL-17  –  induced clinical symptoms identical to those produced 
by WT cells cultured under Th1 polarizing conditions, albeit 
with delayed onset (  Table I  ). Further, in vitro polarization 
played no role in determining the clinical outcome of trans-
ferred IFN-       –  defi   cient cell lines, with equivalent atypical 
clinical manifestations observed in both IFN-       –  defi  cient cell 
lines regardless of previous conditioning (  Table I  ). 
    Figure 1.         Adoptive transfer of Th1-polarized T cell lines generated 
in IFN-      –  defi  cient mice results in atypical CNS infl  ammation.  
MOG  35-55 -specifi  c T cell lines were generated in either C57BL/6 (WT Th1) 
or IFN-     – defi  cient (IFN-         /      Th1) mice. T cells were i.v. injected into WT 
mice at 5   ×   10  6   cells/mouse. (A) 17 d after injection, spinal cord (top) and 
cerebellum (bottom) were collected and stained with hematoxylin and 
eosin (H  &  E) to reveal infl  ammation. (B) Brain stem sections from mice 
that received IFN-         /      Th1 were stained with H  &  E to reveal infl  amma-
tion. (C) A higher magnifi  cation of brain stem sections stained with H  & E 
was used to examine infi  ltrating cell composition. Arrows mark polymor-
phonuclear cells (PMN), monocytes (Mo), and lymphocytes (L). All slides 
shown are representative of sections taken from 12 mice per group over 
six separate experiments. Bars: (A and B) 200   μ  m; (C) 50   μ  m.     
    Figure 2.         T cell lines treated with IL-23 produce high levels of 
IL-17 MOG-specifi  c T cell lines were generated in either C57BL/6 
(WT) or IFN-      –  defi  cient (IFN-          /     ) mice.   T cell lines were produced 
in the presence either of IL-12 or IL-23  + TGF-    + IL-6 +  IL-1 as described in 
Materials and methods. Cells were tested for cytokine production after 
activation with PMA and Ionomycin. Data shown were previously gated 
by forward and side scatter to include lymphocytes. The data shown are 
representative of lines developed in four separate experiments.     2636 IFN-      DIRECTS REGIONAL INFLAMMATION IN EAE   | Lees et al. 
  IFN-     signaling determines CNS lesion localization 
  As lineage commitment appeared to play less of a role in de-
termining lesion localization than the cells  ’   capacity to pro-
duce IFN-     , we hypothesized that IFN-      signaling itself was 
responsible for the diff  erences in clinical course observed, in-
dependent of the eff  ects IFN-      has on T cell diff  erentiation 
and function. To address this hypothesis, we examined the 
capacity of WT MOG-specifi  c encephalitogenic T cells to 
induce classical and/or atypical clinical symptoms in an IFN-
     R  –  defi  cient host. These experiments allowed us to deter-
mine if the observed diff  erences in cell traffi   cking were caused 
by changes in T cell selection and/or activation or by disrup-
tion of cytokine signaling during the invasion process itself. 
  After transfer of WT MOG-specifi  c pathogenic T cells, 
IFN-      receptor (IFN-     R)  –  defi  cient mice developed an atyp-
ical disease identical to that observed with transfer of IFN-       –
  defi  cient eff  ector T cells into WT hosts (  Table III  ).   In addition 
to the appearance of identical clinical symptoms, transfer of 
WT encephalitogenic T cells resulted in histopathology very 
similar to that seen after transfer of IFN-       –  defi  cient cells into 
WT hosts (  Fig. 4  ).   Thus, the IFN-       –  IFN-     R interactions 
involved in determining regions of infl  ammatory pathology 
within the CNS occur long after T cell lineage commitment. 
These data indicate that the determination of regional infl  am-
matory sites most likely occurs during the invasion process it-
self and involves input from the site of tissue infl  ammation. 
  The induction of atypical disease in IFN-    R  –  defi  cient mice 
allowed us to examine the roles of the radiosensitive cells of the 
hematopoetic system and the radioresistant cells of the CNS in 
induction of typical and atypical EAE disease using BM chimeras. 
Examination of the chimeric mice revealed severe symptoms 
of both typical and atypical EAE in mice lacking expression 
of IFN-     R in either radiosensitive cells of the hematopoetic 
system or radioresistant cells of the CNS (Table S1, available at 
http://www.jem.org/cgi/content/full/jem.20080155/DC1). 
  We then used real-time PCR to examine the cerebellum 
and spinal cord of mice with either classical or atypical EAE for 
tissue expression of a variety of molecules previously impli-
cated in CNS autoimmunity (  Fig. 5  ).   Global diff  erences in cere-
bellar expression of the IFN-      –  inducible chemokines CXCL9 
and CXCL10 were observed when tissue from typical and 
analysis of the cerebellum and spinal cord revealed severe in-
fl  ammation in the spinal cord of mice with classical symp-
toms and lesions within the cerebellum of mice that exhibited 
atypical disease, with infi  ltration in both tissues of mice that 
demonstrated both classical and atypical symptoms (  Fig. 3  ). 
Perivascular noninfi  ltrating lesions were also observed in the 
cerebellum of mice that received a 1:5 ratio of Th1/IFN-       –
  defi  cient pathogenic cells but did not demonstrate symptoms 
of atypical disease. This suggested that the reduced lesion area 
was insuffi   cient to drive atypical clinical disease. Thus, al-
though reduced numbers of IFN-       –  producing invading cells 
were suffi   cient to generate infl  ammation within the spinal 
cord, the numbers of Th1 cells present were insuffi   cient to 
completely prevent development of lesions within the cere-
bellum. These data demonstrate that the capacity of IFN-       –
  producing cells to induce infl   ammation within the spinal 
cord and prevent infl  ammation within the cerebellum are 
separable functions, with diff  erent thresholds of Th1 numbers 
necessary for operation. 
  Table II.       IFN-     production in a fraction of pathogenic T cells prevents development of atypical EAE  
Transferred cells Incidence of nonclassical disease Incidence of classical EAE Incidence of both diseases
WT Th1 0/25 21/25 0/25
IFN            /       Th1 22/25 0/25 0/25
WT Th1 + IFN            /       Th1 (1:1) 2/25 24/25 2/25
OVA Th1 + IFN            /       Th1 (1:1) 17/17 0/17 0/17
WT Th1 + IFN            /       Th1 (0.1:1) 11/15 1/15 0/15
WT Th1 + IFN            /       Th1 (0.2:1) 19/30 16/30 6/30
MOG  35-55 -specifi  c T cell lines were generated in either C57BL/6 (WT) or IFN-     – defi  cient (IFN-      KO) mice and polarized to a Th1 phenotype as described in Materials and 
methods. Ovalbumin-specifi  c (OVA) T cell lines were also generated in C57BL/6 and polarized to a Th1 phenotype. Mice received either 5   ×   10  6   WT, 5   ×   10  6   IFN-     KO, 5   ×   10  6  
WT and 5   ×   10  6   IFN-     KO (1:1), 5   ×   10  6   OVA, and 5   ×   10  6   IFN-     KO cells (1:1), 5   ×   10  5   WT and 5   ×   10  6   IFN-     KO (0.1:1), or 1   ×   10  6   WT and 5   ×   10  6   IFN-     KO (0.2:1) as a single 
i.v. injection. Mice were examined over time for clinical signs of limb dysfunction, vertigo/disequilibrium, and ataxia. Results shown were pooled from three separate 
experiments. Results are shown   ±   SD.
    Figure 3.         IFN-     production in a fraction of pathogenic T cells 
protects the cerebellum from infl  ammation.   C57BL6/J mice received 
either 5   ×   10  6   MOG 35-55 -specifi  c Th1 cells generated in C57BL6/J (WT Th1; 
A and B), 5   ×   10  6   MOG 35-55 -specifi  c Th1 cells generated in IFN-     – defi  cient 
(IFN-      KO) mice (C and D), 5   ×   10  6   WT and 5   ×   10  6   IFN-     KO (E and F), or 
10  6   WT and 5   ×   10  6   IFN-     KO (G  –  J) as a single i.v. injection. 17 d after 
injection and after development of classical EAE (A, B, and E  –  H), nonclas-
sical EAE (C and D), or both classical and nonclassical disease (I and J), 
spinal cord and cerebellum were collected and stained with H  & E  to  reveal 
infl  ammation. Representative slides from fi  ve independent experiments 
are shown. Bars, 200   μ  m.     JEM VOL. 205, October 27, 2008 
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genic T cell cytokine profi  les coincided with development of 
atypical EAE in IFN-     R KO mice, we examined the cyto-
kine profi  le of leukocytes recovered from the CNS of WT 
mice or IFN-     R  –  defi  cient mice that received WT patho-
genic cells (  Fig. 6  ).   Interestingly, a high number of the re-
cently described (  18  ) host CD4  -  CD8  -   IL-17  –  producing T 
cells were found in the cerebellum of mice with atypical EAE, 
suggesting that these cells may play a role in the pathogenesis 
of atypical EAE (  Fig. 6  ). However, examination of adop-
tively transferred WT cells revealed no change in IL-17 pro-
duction capacity regardless of the host  ’  s IFN-     R expression 
level and clinical manifestation (  Fig. 6  ). Thus, the changes in 
lesion localization associated with IFN-     R defi  ciency are not 
a result of changes within the pathogenic T cells but instead 
refl  ect the inability of the host to respond to IFN-      produced 
by the invasive T cell. 
    DISCUSSION   
  In this study, we used an adoptive transfer system to examine 
the capacity of IFN-       –  IFN-     R interactions to determine the 
sites of infl  ammation within the CNS. IFN-       –  expressing WT 
Th1 cells were found to initiate similar lesions in IFN-     R  –  null 
hosts as IFN-       –  null cells in WT hosts. These data suggested 
that IFN-      produced by the eff  ector T cell population was 
selectively antiinfl  ammatory in the cerebellum and brainstem. 
In the same mice, IFN-       –  IFN-     R interactions were necessary 
for infl  ammatory infi  ltration of the spinal cord. Together, these 
data demonstrate discrete regional responses to IFN-      during 
neuroinfl  ammation and suggest that these responses can shape 
the clinical manifestation of CNS autoimmunity. 
  The experiments reported here reveal that the previously 
reported eff  ects on EAE clinical outcome associated with IFN-      
defi  ciency are linked to two discrete functions of IFN-      in 
EAE induction. First, recognition of pathogenic T cell  –  pro-
duced IFN-      is necessary to prevent infl  ammation of the cer-
ebellum and brain stem. Adoptively transferred pathogenic 
Th1 cells appear to possess the necessary components for in-
vasion of the cerebellum and brain stem as, in the absence of a 
atypical EAE were compared (  Fig. 5  ). In addition there were 
signifi  cant reductions in the production of IFN-      in mice 
that received IFN-       –  defi  cient cells and reduction in the pro-
duction of TNF-      in IFN-     R  –  defi  cient mice (  Fig. 5  ). 
  The severe Th1 and IFN-     R  –  null were injected in parallel 
with the same Th1 pathogenic T cells. There was similar in-
duction of IFN-      in the cerebellum of both groups, indicating 
similar levels of antigenic stimulation of the transferred lym-
phocytes (  Fig. 5  ). In turn, the diff  erence in spinal cord IFN-      
expression between the two groups supports the hypothesis of 
a strongly proinfl  ammatory role for IFN-      in increasing in-
fl  ammatory cell infi  ltration of the spinal cord in WT mice. 
  Increased numbers of adoptively transferred IL-17  –
  producing cells are not required to drive atypical EAE 
  A recent study suggested that changes in the ratio of IL-17 
and IFN-       –  producing pathogenic T cells determined CNS 
lesion localization (  17  ). To determine if changes in patho-
  Table III.       Host expression of IFN-    R determines clinical outcome after adoptive transfer of CNS pathogenic T cells  
Mouse genotype C57BL6/J IFN-    R KO
Incidence of clinical signs 18/20 19/19
Incidence of clinical signs of limb dysfunction 18/20 14/19
Mean day of onset of clinical limb dysfunction 7   ±   1 10   ±   2
Incidence of fl  accid paralysis 18/20 0/19
Incidence of dystonia 0/20 14/19
Mean peak limb dysfunction clinical score 2.6   ±   1 1.2   ±   0.6
Incidence of clinical signs of nonclassical EAE 0/20 19/19
Mean day of onset of nonclassical signs of EAE NA 10   ±   1
Vertigo/dysequilibrium NA 19/19
Ataxia NA 19/19
MOG  35-55   specifi  c T-cells were generated in C57BL/6 mice and polarized to a Th1 phenotype. The T-cells were then injected IV into either C57BL/6 or IFN-    R – defi  cient (IFN-    R 
KO) mice. Mice were examined over time for clinical signs of limb dysfunction, vertigo/disequilibrium, and ataxia. Results shown were pooled from three separate experiments. 
Results are shown   ±   SD.
    Figure 4.         Defi  ciency of either IFN-     or IFN-    R results in infl  am-
mation of the cerebellum after adoptive transfer of CNS pathogenic 
T cells.   MOG 35-55 -specifi  c T cell lines were generated in either C57BL/6 
(WT Th1) or IFN-     – defi  cient (IFN-      KO Th1) mice in the presence of IL-12. 
T cells were i.v. injected into either C57BL/6 (WT) or IFN-    R – defi  cient 
(IFN-     R KO) mice at 5   ×   10  6   cells/mouse. 17 d after injection, spinal cord 
and cerebellum were collected and stained with H  &  E to reveal infl  amma-
tion. Perivascular lesions and invasive parenchymal lesions are indicated 
with an arrow and the letters P and I, respectively. Representative slides 
from three independent experiments are shown. Bars, 200   μ  m.     2638 IFN-      DIRECTS REGIONAL INFLAMMATION IN EAE   | Lees et al. 
genic T cell  –  produced IFN-      is required for the induction of 
infl  ammation within the spinal cord. That is, in the absence 
of an IFN-      signal, adoptively transferred cells are not capa-
ble of initiating spinal cord infl  ammation. Interestingly, some 
mice showed symptoms of paralysis in the absence of measur-
able spinal cord infi  ltration. Unlike the ascending paralysis ob-
served in classical EAE, the limb dysfunction that occurred in 
mice with the atypical clinical course was not necessarily cau-
dal to rostral, as mice could demonstrate hind- and/or forelimb 
weakness and/or dystonia in the absence of tail involvement. 
These fi  ndings suggest that the observed dystonia is induced 
by either infl  ammatory lesions within the spinal cord too small 
to be detected using standard histological techniques or, more 
likely, is induced by lesions within the cerebellum and/or 
brain stem. Together, these data reveal that encephalitogenic 
eff  ector T cell cytokine production and concomitant host rec-
ognition of the cytokine plays a vital role in localizing the 
lesions associated with classical EAE. 
  Previous reports suggested that diff  erences in cell localiza-
tion followed from recognition of distinct antigens (  6, 19  ). 
Alternatively, it has been suggested that diff  erences in cellular 
localization refl  ected anatomical diff  erences in the capacity 
to support T cell invasion through breakdown of the blood  –
  brain barrier (  10, 20, 21  ). Several groups previously demon-
strated the induction of atypical axial-rotary disease in a variety 
of EAE models, and particularly within IFN-       –  defi  cient mice 
(  6, 7, 22  –  24  ). Reports suggested that the nature of the disease 
in IFN-       –  defi  cient systems refl  ected biased selection of the 
T cell repertoire, either through direct manipulation of the 
T cells themselves or by infl  uencing the range of antigens 
presented to T cells during initiation of the immune response 
(  7  ). However, another group used a TCR transgenic mouse 
host response to IFN-     , these cells are fully capable of infi  l-
trating and initiating cerebellar disease. However, under 
ordinary circumstances the IFN-      produced by the encepha-
litogenic cells is suffi   cient to prevent entry of the same cells 
into the cerebellum and brainstem. As such, IFN-       –  mediated 
protection of the cerebellum and brain stem represents an ac-
tive process, acting under ordinary circumstances to prevent 
cerebellar infl  ammation. Second, recognition of encephalito-
    Figure 5.         CNS expression of EAE-associated infl  ammatory proteins 
changes in the absence of an IFN-     signal MOG  35-55  -specifi  c T cell 
lines were generated in either C57BL/6 or IFN-      –  defi  cient mice 
and polarized to a Th1 phenotype.   T cells were injected IV into either 
C57BL/6 or IFN-    R – defi  cient mice at 1   ×   10  7   cells/mouse. Between 24 and 
48 h after disease onset, mRNA was extracted from spinal cord and cer-
ebellum and examined for infl  ammatory expression patterns using real 
time PCR as described in Materials and methods. Moderate Th1 tissue was 
extracted from animals that exhibited classical clinical scores of 1  –  2 in 
the 24  –  48 h after onset. Severe Th1 tissue was extracted from mice that 
exhibited classical clinical scores of 2.5  –  3.5 during the same period. The 
cells used to induce the severe EAE were injected in parallel into IFN-    R –
 defi  cient mice (IFN-     R null). The tissue in the IFN-     – null  group  was  ex-
tracted from WT mice that received IFN-     – defi  cient pathogenic T cells. 
The data are presented as mean   ±   SEM of 4  –  5 mice/group from two inde-
pendent experiments.     
    Figure 6.         Atypical infl  ammation in IFN-    R  –  defi  cient mice does 
not require increased Il-17 production in adoptively transferred 
cells.   MOG 35-55 -specifi  c T cell lines were generated in CD90.1  +   C57BL/6 
mice and retroorbitally injected into either C57BL/6 (WT) or IFN-    R – defi  -
cient (    R     /     ) mice at 5   ×   10  6   cells/mouse. After disease onset, T cells were 
recovered from either the cerebellum and brainstem or the spinal cord. 
T cells were restimulated with PMA and Ionomycin and tested for their 
capacity to produce IFN-      and IL-17. Perivascular lesions and invasive 
parenchymal lesions are indicated with an arrow and the letters P and I, 
respectively. Data shown is representative of three separate experiments 
that used tissue pooled from two mice.     JEM VOL. 205, October 27, 2008 
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in accord with the recent observations of Stromnes et al. (  17  ), 
the induction of atypical disease in IFN-     R  –  defi  cient mice 
given WT cells indicates a very diff  erent mechanism active 
in our system. Although their results suggested that IL-17 was 
essential to the induction of atypical disease, the data shown by 
Stromnes et al. (  17  ) could also support the fi  nding that di-
lution of IFN-       –  producing pathogenic T cells with patho-
genic cells incapable of producing IFN-      results in atypical 
disease, as reported in this paper. 
  Interestingly, Stromnes et al. (  17  ) found that administra-
tion of IL-17RA  –  Fc protein preferentially blocked atypical 
disease induction. Combined with the cerebellar recruitment 
of host IL-17  –  producing cells seen in atypical disease, these 
data suggest that IL-17 plays a vital role in atypical EAE. 
However, these data do not demonstrate that IL-17 is re-
sponsible for lesion localization to the cerebellum and brain-
stem but only that the atypical disease process requires IL-17 
at some time during the pathogenesis process. Indeed, it is per-
haps more surprising that administration of the IL-17RA  –  Fc 
protein had so little eff  ect on classical EAE incidence and symp-
toms in this model, a fi  nding that contrasts with studies that 
reported a profound eff  ect of IL-17 blockade on classical EAE 
induction (  25, 26  ), than that IL-17 is required to drive atypi-
cal EAE. Although it remains possible that IL-17 production is 
required for lesion localization to the brain after immuniza-
tion with MOG  97  –  114  , it is equally possible that the neces-
sary role for IL-17 in pathogenesis within the brain occurs 
after site selection. 
  The diff  erences in cell traffi   cking presented in the cell 
mixing experiments illustrate the discrete nature of the pro- 
and antiinfl  ammatory (protective) aspects of IFN-     R signal-
ing. Although initial experiments left open the possibility that 
spinal cord invasion and cerebellar invasion were mutually ex-
clusive, the histological and clinical data from the cell mixing 
experiments and BM chimeras clearly demonstrate the capac-
ity for these two infl  ammatory pathways to occur simultane-
ously. Thus, the IFN-      –  meditated protection of the cerebellum 
and brain stem and infl  ammation of the spinal cord are sepa-
rable events. 
  The data presented here support previous studies that dem-
onstrated diff  erential responses to IFN-      in discrete portions of 
the brain (  27, 28  ). These studies clearly demonstrated a diff  er-
ential capacity for IFN-      responses within various sections of 
the brain after exogenous cytokine administration. In contrast, 
the data presented here delineate diff  erential responses to physio-
logical levels of IFN-      production. This diff  erence in meth-
odology may explain the apparent discrepancies between 
IFN-       –  induced cell traffi   cking into the brainstem in the earlier 
study (  27  ) and the IFN-       –  induced protection from cell traf-
fi  cking observed in the brainstem in this study. 
  The idea that regional CNS responses to cytokines are 
vital to the development of neuroinfl  ammation also fi  ts well 
with previous MS studies that demonstrated anti-myelin T 
cell responses in clinically silent individuals (  29  –  33  ). The lack 
of clinical manifestation in individuals that are clearly capable 
of a vigorous antimyelin immune response could be explained 
incapable of mediating T cell receptor recombination to dem-
onstrate that T cells with identical specifi  cities were capable 
of inducing either classical or atypical EAE depending on the 
conditions under which the cells were generated (  12  ). Al-
though clearly demonstrating the capacity of a single TCR to 
initiate either atypical disease or classical EAE, the study did 
not determine if the diff  erence in pathogenesis observed was 
a result of specifi  c programs induced in the T cells themselves 
or if pathogenesis resulted from diff  erential cytokine produc-
tion and thus target tissue susceptibility. 
  In this study we demonstrate, using adoptive transfer of 
WT Th1 cells into IFN-     R  –  defi  cient mice, that localization 
of T cells to specifi  c regions of the brain relies on IFN-       –
  IFN-     R interactions during the invasion process. A single T 
cell preparation is able to induce atypical and/or classical dis-
ease depending on whether cells within the host are capable 
of recognizing IFN-     . Thus, regional diff  erences in T cell 
invasion represent regional diff  erences in cytokine respon-
siveness rather than any intrinsic diff  erences in the individual 
initiating T cells. 
  The mixing experiments demonstrate that the capacity 
for IFN-      expression in only 50% of initiating T cells is suffi   -
cient to drive both protection of the cerebellum and infi  ltra-
tion of the spinal cord. Further, protective IFN-      production 
required antigenic stimulation of invading Th1 cells. (  Table II  ) 
This suggests that both protection eff  ects and infi  ltration are 
initiated by host cell recognition of an IFN-      signal produced 
by a portion of CNS antigen-specifi  c invading cells. Invading 
cells are not necessarily discriminated on an individual basis, 
rather the overall group makeup determines tissue receptive-
ness to invasion. 
  This fi  nding is particularly intriguing in light of a recent 
study that suggested that IL-17/IFN-       –  producing tissue in-
vasive cell ratios determine the localization of T cell invasion 
and lesion formation (  17  ). In contrast to the results demon-
strated in the current study, Stromnes et al. (  17  ) found that 
IL-23  –  treated MOG  35-55   cells were capable of inducing atyp-
ical EAE in WT mice. This capacity was linked to the change 
in the ratio of IL-17/IFN-      T cell ratios as found in the 
CNS. Given the large number of IFN-       –  producing cells still 
found in our IL-23  –  treated pathogenic T cells, it is perhaps 
not surprising that we found no capacity for IL-23  –  treated cells 
to induce atypical EAE. 
  The data presented here clearly demonstrate that inter-
ruption of IFN-     /IFN-     R signaling resulted in redistribu-
tion of lesions from the classical pattern of spinal cord to the 
cerebellum and brain stem. However, it remained possible that 
the disruption of IFN-     /IFN-     R signaling lay upstream of a 
change in cytokine production capacity that resulted in the 
skewed IL-17/IFN-      ratios reported by Stromnes et al. (  17  ) 
Examination of cytokine production in WT pathogenic T cells 
after transfer into IFN-     R revealed almost no change in IL-17/
IFN-      ratio, demonstrating that in our system an increased 
IL-17/IFN-      ratio is not required to induce atypical disease. 
As such, although the demonstration that decreasing the frac-
tion of IFN-       –  producing cells increases atypical disease is 2640 IFN-      DIRECTS REGIONAL INFLAMMATION IN EAE   | Lees et al. 
of the CNS. An understanding of the exact mechanisms in-
volved in cellular localization to the CNS and PNS may al-
low development of better methods for determining prognosis 
and modifying pathogenesis in many neurological diseases 
such as MS, BBE, MFS, and GBS. 
  MATERIALS AND METHODS 
  Mice.     C57BL/6J, congenic CD45.1 mice, IFN-     R KO, and IFN-       –  defi  cient 
B6.129S7-ifng  tm1Ts  /J mice were purchased from Jackson ImmunoResearch 
Laboratories. All experiments were approved by the Washington University 
Animal Care Committee and all mice were housed in an Association for Asses-
ment and Accreditation of Laboratory Animal Care  –  approved facility. 
  T cell lines.     To generate MOG-specifi  c cell lines, C57BL/6J or IFN-       –
  defi  cient B6.129S7-ifng  tm1Ts  /J mice were immunized s.c. with 50   μ  g MOG  35-55   
peptide (Sigma-Aldrich) emulsifi  ed in IFA and supplemented with 500   μ  g/ml 
  Mycobacterium tuberculosis  . CD4  +   cells were isolated from the spleen as 
previously described (  46  ). Cells were then stimulated at a concentration of 
10  6   cells/ml in the presence of 5   ×   10  6   cells/ml of irradiated C57BL/6 sple-
nocytes, 10   μ  g/ml MOG  35-55   peptide, 10 U/ml IL-12, and 10 U/ml IL-2, in 
10% FCS containing RPMI complete media to polarize cells to a Th1 phe-
notype or in the presence of 5   ×   10  6   cells/ml of irradiated C57BL/6 spleno-
cytes, 10   μ  g/ml MOG  35-55   peptide, 1   μ  g/ml of human TGF-     1, 10   μ  g/ml 
of mouse IL-6, 10   μ  g/ml of recombinant mouse IL-23, 1 mg/ml of neutral-
izing antibody to IFN-     , and 10 U/ml IL-2, in 10% FCS containing RPMI 
complete media to polarize cells to a Th17 phenotype. Cells were isolated 
7 d later by Histopaque 1.077 (Sigma-Aldrich) and then restimulated in the 
absence of IL-12 under the other conditions outlined earlier in the section. 
Cells underwent two rounds of stimulation before being stored at      70  °  C in 
10% DMSO containing FCS. Before usage, cells were thawed and restimu-
lated for 7 d with MOG peptide and IL-2. Before injection, cells were re-
stimulated for 4 d with MOG peptide and IL-2, separated by Histopaque 
1.077, and then washed and resuspended in HBSS. To induce EAE, 5   ×   10  6   
cells in 300   μ  l HBSS was transferred by retroorbital i.v. injection to 6  –  8-
wk-old mice. Ovalbumin-specifi  c (OVA) T cell lines were produced using 
the same protocol with 900   μ  g of whole ovalbumin protein substituted for 
MOG  35-55   peptide. 
  Clinical scoring.     Mice were examined daily for symptoms. Symptoms of 
limb dysfunction were scored based on areas aff  ected (1, partial or total in-
ability to move tail; 2, hind limb weakness/disrupted righting refl  ex; 3, com-
plete inability to move hind limb; 4, complete inability to move both hind 
limbs; 5, moribund/dead) and type of dysfunction (fl  accid or dystonic). Inci-
dence of atypical EAE was assigned if limb dysfunction associated with dysto-
nia occurred or if symptoms of either ataxia or vertigo/dysequilibrium were 
recorded on any given day. Incidence of classical EAE was determined based 
on appearance of limb dysfunction associated with fl  accid paralysis. Symp-
toms of ataxia were determined separately for the head, each individual limb 
quarter, and the tail. Symptoms of vertigo/dysequilibrium were scored based 
on side aff  ected and severity. 
  Histological examination.     Mice were perfused with 30 ml of ice-cold saline. 
CNS tissues were extracted through mechanical removal of upper skull and 
vertebrae. Desired tissues were immediately removed from the whole CNS and 
placed in embedding media before being frozen on dry ice. Tissues were kept 
at      80  °  C until being sectioned in 10-  μ  m slices and stained with H  &  E. 
  Intracellular cytokine staining.     Intracellular staining was performed, 
with some modifi  cation, as previously described (  47  ). In brief, 10  6   cells were 
restimulated on plates precoated with anti-CD3 (10   μ  g/ml PBS; eBiosci-
ence) or by incubation with 50 ng/ml PMA and 1   μ  M ionomycin (Sigma-
Aldrich), with concurrent blockade of cytokine secretion by treatment with 
1   μ  g/ml brefeldin A (Sigma-Aldrich) for 2  –  4 h at 37  °  C. Cells were stained 
with anti-CD4 on ice for 15 min with continual agitation. Cells were then 
washed three times with PBS supplemented with 0.5% BSA and 0.1% 
by CNS responses that are either insuffi   cient to allow infl  am-
mation or that are actively suppressive of infl  ammation. Under 
this model, development of MS would rely on both induc-
tion of CNS specifi  c autoimmune responses and the capacity 
of the CNS to respond to initial immune invasion. 
  Interestingly, initial examination of IFN-     R1 within the 
cerebellum and spinal cord of both naive mice and mice with 
either typical or atypical EAE revealed little to no diff  erence 
in expression between the two tissues. These data suggest that 
the capacity to bind IFN-      is equivalent between the two 
tissues and that diff  erential responses to IFN-      within diff  er-
ent regions refl  ect downstream components of the IFN-      
signaling pathway (unpublished data). 
  The expression of both CXCL9 and CXCL10 were 
completely ablated in the CNS of mice that did not receive 
an IFN-      signal from invading T cells. These data demonstrate 
that in our model system, alternative infl  ammatory agents 
such as TNF-     are not suffi   cient to drive expression of CXCL9 
and CXCL10. The complete absence of these chemokines in 
the cerebellum of mice with atypical disease supports recent 
suggestions that these chemokines restrain T cells within the 
perivasculature of the cerebellum preventing development of 
atypical disease (  34  ). 
  The data presented here demonstrate the suffi   ciency and 
necessity for IFN-      signaling during the invasion process to 
determine cellular localization within various anatomical com-
ponents of the CNS. The atypical EAE model may give useful 
information for cerebellar MS but it may also tell us about 
other infl  ammatory diseases. The atypical EAE fi  ndings de-
scribed here may be a particularly good model of the human 
disease, Bickerstaff    ’  s brainstem encephalitis (BBE) (  35  ). This is 
usually a monophasic infl  ammatory disease of the brainstem 
and cerebellum. Patients have decreased consciousness, corti-
cospinal tract abnormalities, multiple cranial nerve dysfunc-
tions, and ataxia. Its less severe form appears to be Miller Fisher 
syndrome (MFS), which has much less brainstem involvement 
and is defi  ned by ophthalmoplegia, ataxia, and arefl  exia. The 
diff  erences between BBE and MFS, although controversial, 
may be a matter of the intensity of the immune response, given 
that both aff  ect the same target areas of the brain (  36, 37  ). MFS 
in turn overlaps with Guillain Barre syndrome (GBS). It is of 
interest that BBE, MFS, and a subset of GBS can have seem-
ingly similar immune responses (all can have similar anti-
GQ1B ganglioside antibodies) (  38  –  41  ), yet have diff  erent 
infl  ammatory targeting (  42  ). Diff  erences in IFN-      production 
in these diseases could account for these diff  erences if they fol-
low the same paradigm as described in our atypical EAE model. 
As would be predicted by our disease paradigm, patients with 
MFS have lower IFN-      production than patients with GBS 
(  43  ). Also, cases have been described that started as one of 
these diseases that then changed or relapsed as a diff  erent dis-
ease (  44, 45  ). Fluctuations in IFN-      production might be ex-
pected to produce exactly this scenario. 
  The data presented here demonstrate the suffi   ciency and 
necessity for IFN-      signaling during the invasion process to 
determine regional localization within various anatomical sites JEM VOL. 205, October 27, 2008 
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sodium azide (SB), fi  xed with 5% buff  ered formalin phosphate (5% paraformal-
dehyde in PBS) for 20 min at room temperature, washed with PBS, and 
permeabilized with PBS supplemented with 0.5% BSA, 0.1% sodium azide, and 
0.1% saponin (PB) for 10 min at room temperature. Cells were then washed 
once with PB, and stained with 5   μ  g/ml of anti  –  IL-17A-PE or APC and/or 
anti  –  IFN-     -FITC or APC or isotype controls (eBioscience) in PB for 5 min at 
room temperature with continual agitation. After washing twice with PB and 
twice with SB, cells were immediately collected using a FACSCalibur (BD Bio-
sciences) and were analyzed using CellQuest software (BD Biosciences). 
  Quantitative PCR.     All experiments were performed as previously de-
scribed (  48  ). Previously described primer sets were used, including IFN-     , 
CXCL10, and GAPDH (  48  ); CXCL2 (  11  ); CXCL9 (  49  ); IL-12p35 and 
IL-23p19 (  50  ); and IL-17 (  51  ). Individual copy numbers were normalized to 
copies of GAPDH. 
  Statistics.     All statistics were performed using Prism 4 software (GraphPad 
Software, Inc.). 
  Online supplemental material.     Fig. S1 shows the immune cell constitu-
ents of CNS tissue from typical and atypical disease. Table S1 shows that de-
fi  ciency of IFN-     R in either radioresistant or BM-derived cells results in 
a loss of cerebellar protection. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20080155/DC1. 
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